Free Newsletter
Privates continue to lag public clouds
As Amazon continues to distance itself from the public-cloud computing provider pack, private clouds remain a not-ready-for-prime-time alternative. So says Chris Dagdigian of high-performance computing consultancy BioTeam.
Dagdigian spoke at the recent Bio-IT World Europe conference. In a published interview, he says that viable private cloud computing--for life-sciences applications, at least--remain one or more years in the future. The reason: inadequate flexibility of internal network architecture for meeting business and scientific needs.
A major appeal of private networks over clouds, of course, is their tighter data security--a storage issue that instantly attracts C-level attention, in contrast to the science-driven computing requirements that lead researchers to the cloud in the first place. But public cloud providers and users alike contend that security concerns are overblown. Now they just have to get the corporate suite to listen. Or are the corporados right?
- read the Dagdigian interview
- see our Fierce cloud services report
Related Articles:
J&J culls apps for move to cloud
The cloud that broke the CIOs' backs
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




